PCOS to PMOS: What the Name Change Means for Women’s Health

Smart Medicine  |  28 August 2026

For ninety years, the name we gave one of the most common conditions in women’s health pointed everyone in the wrong direction.

In this episode of Smart Medicine, Dr. Scott Sigman sits down with Dr. Melanie Cree, a pediatric endocrinologist, who helped lead the international effort to rename polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). Dr. Cree explains the condition at its core, why the old framing left most patients undiagnosed, and shares early data on GLP-1s that points to a new path forward. She also has a direct message for frontline clinicians that not only impacts the women affected by this condition but the healthcare system at large.

If you want to understand where women’s health is headed, start here.

Subscribe to Smart Medicine

Spread the word

Tags
Smart Medicine   Podcasts   Women’s Health   PCOS   PMOS   Endocrinology   Metabolic Health   GLP-1   Hormonal Health   Healthcare Innovation   Melanie Cree   Scott Sigman  

Related insights